San Francisco, California, March 23, 2021—Wave 80 Biosciences today announced a major expansion of its IP portfolio with the issuance of U.S. Patent 10,955,067, Methods and Systems for Enhanced Microfluidic Processing. This expansive patent describes wide-ranging microfluidic architectures for carrying out sophisticated assay processes, including sample preparation and hybridization. The new patent complements and expands on the core liquid micropiston technology covered under the company’s U.S. Patent 9,995,412 issued earlier.
Collectively, the patents cover highly differentiated technologies for a variety of assay processes with compelling applications in fields including next-generation sequencing, cell and gene therapy, and diagnostics.
